Elanco's stock outperforms S&P 500 in 2026

Following the guidance raise and favorable sector tailwinds in animal health, Elanco's stock is positioned to outperform the broader market. If revenue and earnings meet or exceed guidance, investors will reward the stock with relative strength.

Implied probability (Yes)

65%